Monday, November 2, 2026

Kim Ha-seong’s Stunning Comeback: 3 Hits in a Single Game Boosts Season Batting Average

Kim Ha-seong rebounds with three hits, raising his batting average above .100 after a tough slump with the Atlanta Braves.

Alteogen Achieves Gold Medal in 2026 EcoVadis ESG Rankings: What This Means for Sustainable Business

Alteogen has received a Gold Medal in the 2026 ESG assessment from EcoVadis, ranking in the top 5% of companies globally.

Satellite Snaps North Korean Ships in Suspicious Sea Exchange

As illegal ship-to-ship transfers that were previously...

Health

Unlock Your Health: Discover the New AI-Powered BioAge and Health Coach Services from DaNaA Data

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

How the New Medical School in Namwon Can Transform Regional Healthcare: Insights from Lawmaker Park Ji-won

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Ardens Lifescience Triumphs: How a Korean Startup Won 175,000 USD at MedTech Innovator APAC 2026

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Unlocking the Future of Healthcare: Daewoong’s AI-Powered Smart Hospital at AI EXPO MARS 2026

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

10 Years of Excellence: Seoul’s APLAR Center Hosts International Rheumatology Training for Young Specialists

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.
Latest

Wontech to host ‘Wave Tokyo’ in Japan, officially launch SANDRO Dual

Wontech will host "Wave Tokyo" on April 26 to launch SANDRO Dual, expanding its presence in Asia after "Wave Beijing."

ADHD Medication Misconceptions: Why Korean Teens Are Misusing Study Drugs

ADHD medications are misused by teens as smart drugs. The Ministry of Food and Drug Safety expands education and AI monitoring to combat this.

Carelabs enhances ‘HealO’ service to strengthen cancer treatment information search

Carelabs upgraded its HealO platform for cancer care, enhancing information access from diagnosis to recovery for patients and caregivers.

1 Person, 1 AI: Discover SNUH.AI’s Game-Changing Medical Assistant Platform

Seoul National University Hospital's SNUH.AI aims to empower healthcare professionals with AI assistants for improved efficiency and personalized care.

Moderna secures EU approval for combined influenza-COVID vaccine mCOMIRNATY

Moderna's mCOMIRNATY, a combined COVID-19 and influenza vaccine, gains European approval for adults 50+, enhancing its respiratory portfolio.

Penetrium Bioscience Announces Finalization of New Clinical Strategy for Targeted Cancer Therapies

Penetrium Bioscience reveals new clinical strategy to combat drug resistance in cancer therapies at AACR 2026, launching Phase 2 trials.

South Korea’s ARPA-H Project Revolutionizes Elderly Mental Health Solutions

South Korea will officially enter 'super-aged society' by late 2024 or early 2025, raising concerns over elderly mental health issues.

SillaJen’s Breakthrough Cancer BAL0891 Drug Set for ASCO 2026 Reveal

SillaJen's anticancer drug BAL0891 will be presented at the ASCO Annual Meeting, currently in Phase 1 trials for solid tumors and AML.

Nesuparib: The Revolutionary Dual-Inhibitor for Pancreatic Cancer – Can It Outperform Existing Treatments?

Nesuparib shows promise in inhibiting pancreatic cancer metastasis, offering hope for patients regardless of BRCA mutation status.

Lunit’s AI-based bile duct cancer study selected for rapid oral presentation at U.S. oncology conference

Lunit will present five research abstracts at ASCO 2026, showcasing the expanding role of AI biomarkers in cancer treatment.

Verismo unveils preclinical data on improved antitumor efficacy and safety of blood cancer CAR-T at AACR

HLB Innovation's SynKIR-310 shows improved antitumor activity and safety in preclinical trials, achieving 100% survival in mice.

JW Life Science launches medical care brand “Dr. Claro”

JW Life Science launches "Dr. Claro," a medical care brand with five certified products for wound management and skin protection.

CG Bio’s EasyMade TI: The First Custom Titanium Implant Approved by FDA 510(k) – What It Means for Patients

CG Bio's EasyMade TI titanium implant receives FDA 510(k) approval, marking a milestone for customized implants in the U.S. market.

Stage 3 lung cancer patients over 70 can receive “active treatment” so “should not give up”

A study shows elderly patients (70+) with stage 3 lung cancer can complete standard treatment, challenging age-related treatment hesitance.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.